Pharmaceutical Online Videos
-
KBI BioPharma Capabilities Update July 2026: Large Molecule
8/3/2026
Combining targeted transposon tech with stable bulk pool generation accelerates cell line development, enabling early material production and fast-tracking candidate selection for clinical entry.
-
AbbVie Capabilities Update July 2026: Large Molecule
8/3/2026
Integrated manufacturing networks de-risk biopharmaceutical scale-up. Flexible mammalian platforms and advanced ADC conjugation ensure strict quality standards and long-term commercial supply.
-
Pace Life Sciences Capabilities Update July 2026: Fill/ Finish
8/3/2026
Flexible CDMO networks separate early formulation from clinical fill-and-finish, using manual and automated isolators to protect delicate modalities while accelerating trial timelines.
-
Ardena Capabilities Update July 2026: Fill/Finish
8/3/2026
Grade A isolators and sterilization protect delicate biologics. Precision container closures maintain integrity down to -80°C, ensuring full compliance across clinical fill-and-finish workflows.
-
Expert Small Molecule Drug Development And Manufacturing Solutions
8/1/2026
Backed by decades of chemistry expertise, this organization emphasizes technical rigor, transparency, and responsiveness to support long-term partnerships.
-
Safety Of Injectables: Ensuring Purity Via Endotoxin Testing
7/28/2026
Advance pharmaceutical quality and sustainability by adopting recombinant factor C testing for reliable, animal-free endotoxin detection.
-
AST's Latest Generation GENiSYS® R: Available With Accelerated Delivery
7/28/2026
Automated robotic fill-finish and integrated isolator technologies streamline multi-format parenteral manufacturing while ensuring regulatory compliance and maximum yield.
-
Fewer Setbacks, Faster To IND
7/25/2026
Cy Credille, Group Leader in process chemistry at Cambrex Longmont, on the setbacks that come as standard in early development — and why a team that has seen them all before is the fastest route to the IND finish line.
-
Ask Us Anything: Cy Credille
7/24/2026
Learn how we balance discovery and development as an asset scales, and how the One Cambrex model keeps the original process scientists attached to a molecule from first kilos through NDA.
-
Ask Us Anything: Eric Fang On Lithiation Chemistry
7/24/2026
Eric Fang, General Manager of Snapdragon Chemistry, on why lithiation chemistry resists batch scale-up — and how a decade spent understanding static mixing lets Snapdragon carry these reactions from milligrams to metric tons.